AcuCort AB (publ) (NGM:ACUC)
Sweden · Delayed Price · Currency is SEK 0.7130
-0.0280 (-3.78%)
At close: Jul 7, 2025
AcuCort AB Company Description
AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.
It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment.
AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
AcuCort AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 4 |
| CEO | Jonas Jonmark |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Website | acucort.com |
Stock Details
| Ticker Symbol | ACUC |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jonas Jonmark | Chief Executive Officer |